With the number of Tylenol liver failure lawsuits continuing to increase as more victims of dosage problems with the pain-killer acetaminophen come forth there is the possibility that this litigation could evolve into a massive class-action case.
These cases involve allegations that even when some patients follow recommended dosages severe liver problems can occur, including liver failure.
Named as defendants in some of the suits involving Tylenol products are McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson.
Acetaminophen liver failure lawyers have filed lawsuits on behalf of victims who claim the defendants marketed and sold over-the-counter Tylenol products while failing to adequately warn patients about the serious risks of liver toxicity or failure that could be caused by these products.
Among the products that have been named in acetaminophen lawsuits are aspirin, ibuprofen, naproxen, Regular Strength Tylenol, Extra Strength Tylenol, regular-strength store brand/generic acetaminophen, extra-strength store brand/generic acetaminophen, Nyquil, Vicodin, Percocet and NSAIDS (nonsteroidal antinflammatory drugs).
Acetaminophen liver failure lawyers have announced they are still reviewing such cases to determine what compensation may be available for those who have suffered liver problems and incurred medical expenses and suffered loss of wages.
These acetaminophen liver failure lawyers are also offering free consultations to liver failure victims to outline the legal options available to those eligible to file an acetaminophen liver failure lawsuit.
Recent news reports show that there is a pending motion before the United States Judicial Panel on Multidistrict Litigation to consolidate such cases before a federal judge in Philadelphia.
What happens if such a request is granted? If the panel decides to refer the cases to a single judge that individual then oversees and coordinates pre-trial evidence gathering and other legal proceedings.
Essentially, similar cases – such as those in the acetaminophen liver failure lawsuits – against the same defendants are brought under one roof to streamline the process.
The judge may approve the questioning of company officials by lawyers for the victims and allow the defendant’s lawyers access to victims’ medical records to ensure that the injuries are documented.
Legal experts say that trial cases may be scheduled to allow both sides to test the strengths and weaknesses of their cases and that the judge will be asked to certify the cases as a massive class-action.
These experts say past history shows that in many defective-drug class-action cases there have been multi-million dollar settlements paid out to victims who have suffered health problems, loss of wages, pain and suffering and other expenses.
The U.S. Food and Drug Administration has already acknowledged serious concerns about the risks of liver failure among acetaminophen users. Here is a warning that has now been put in place by the agency about acetaminophen toxicity:
“Acetaminophen is one of the most commonly used medicines in the United States. When used according to the label directions, it has a well-established record of safety and efficacy. Although acetaminophen overdose is very rare in the context of its broad usage, overdose can be toxic and lead to acute liver failure.
“Liver injury from acetaminophen overdose remains a serious public health problem despite ongoing regulatory and educational efforts over the past several years to improve the safe use of medicines that contain acetaminophen. Patients can take too much if they take more than the labeled dose of one acetaminophen medicine, or if they take more than one medicine containing acetaminophen (for example, an over-the-counter [OTC] medicine that contains acetaminophen with a prescription medicine that contains acetaminophen).
“To prevent acetaminophen overdose, consumers need to be able to read labels and recognize when their medicines contain acetaminophen. The active ingredients in OTC medicines are clearly listed on the label, but the container labels on prescription medicines that contain acetaminophen may not clearly identify acetaminophen as an active ingredient.”